<DOC>
	<DOCNO>NCT02690467</DOCNO>
	<brief_summary>The purpose study determine non-inferiority new Pic Insupen 34Gx3,5mm needle vs. 32Gx4mm needle term metabolic control , safety acceptability patient diabetes treated insulin .</brief_summary>
	<brief_title>Efficacy , Safety Acceptability New Pen Needle 34gx3,5mm .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients type 1 type 2 diabetes Age &gt; = 18 year Multiple daily injection insulin least 6 month Signed informed consent Pregnancy breast feed Inability fill questionnaire Combined therapy diabetes ( oral drug associate insulin injection ) Any medical condition could interfere study accord investigator 's opinion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Insulin therapy</keyword>
	<keyword>Needle</keyword>
</DOC>